Last reviewed · How we verify

NCT07119307

Papilla Preservation Technique in Combination With Tooth Enamel Proteins and Animal Derived Bone Graft in Treating Isolated Bone Defects Between Teeth

Completed Phase 4 Last updated 15 September 2025
What this trial tests

Phase 4 trial testing Entire Papilla Preservation Technique in Periodontal Diseases in 58 participants. Completed in 30 March 2025.

Timeline
30 May 2023
Primary endpoint
30 January 2025
30 March 2025

Quick facts

Lead sponsorRungta College of Dental Sciences and Research
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment58
Start date30 May 2023
Primary completion30 January 2025
Estimated completion30 March 2025
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Rungta College of Dental Sciences and Research

Who can join

Adults 18 to 60, any sex, with Periodontal Diseases or Intrabony Periodontal Defect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present three-arm study compared the clinical and tomographic efficacy of the Entire Papilla Preservation Surgical Technique (EPPT) alone and combined with enamel matrix derivative (EMD) plus bone mineral derivedxenograph (BMDX), in the treatment of isolated, inter-dental intra-bony defects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other Rungta College of Dental Sciences and Research trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07119307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing